Article
A CME Symposium held during the AAO & SOE 2004 Joint Meeting in New Orleans.
Stuart Therapeutics completes Phase 3 trial of vezocolmitide for treatment of dry eye disease
California dreaming: 2025 Glaucoma 360 brings celebration, innovation, and education to San Francisco
BLINK2 study confirms lasting myopia control benefits in teenagers
Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025
HelpMeSee announces new training partnerships, simulation training sites
Glaukos announces several positive clinical updates for its iDose platform